Nan Wang

Nan Wang is a legal and compliance professional with a strong background in the pharmaceutical industry. They served as an Associate at Kobre & Kim from 2016 to 2020, specializing in cross-border disputes and internal investigations related to the Foreign Corrupt Practices Act. Currently, Wang holds the position of Executive Director, Ethics & Compliance Core Capabilities/Business Partner at Eli Lilly and Company, where they advance compliance programs and provide strategic support to the Central Marketing Organization. Wang also possesses academic experience as a Teaching Assistant at the University of Wisconsin Law School, where they instructed LL.M students in American law. They earned a Bachelor of Law in Economic Law from East China University of Political Science and Law, followed by both a Master of Legal Institution and a Juris Doctor from the University of Wisconsin Law School.